CReATe Podcast

50 episodes listed below

Listen to the show on

ALS research, carefully translated.

The gist

CReATe Podcast sits at the meeting point of ALS research, clinical guidance, and patient-facing explanation. Its episodes turn publications and ALS Untangled reviews into plain-spoken interviews about what evidence can and cannot yet show.

PRESS PLAY

Find your next episode

All episodes

About CReATe Podcast

CReATe Podcast is an ALS and motor-neuron-disease research show with a clear educational purpose. It turns consortium publications and ALS Untangled reviews into guided conversations for people who need the science explained without being flattened. Recent Author Series episodes center on MMI as a prodromal stage of ALS, C9orf72 disease-prevention trials, exercise and ALS, and clinical guidance for people at elevated genetic risk for ALS/FTD. Those topics are technical. The show meets them directly, using questions about phenoconversion, penetrance, mTOR signaling, endpoints, biomarkers, and clinical-trial design to show why small definitions can matter so much. The ALS Untangled strand is more evaluative. It examines alternative and off-label treatments such as the Wahls Protocol, psilocybin, ashwagandha, and zinc, asking what evidence exists, where animal or cell data may mislead, and whether potential benefits outweigh harms. The result is not a simple yes-or-no consumer guide. It is a habit of reasoning in public. A treatment can be cheap, available, or biologically plausible and still lack evidence for slowing ALS. Another can have enough signal to justify attention while still needing trial results before anyone treats it as settled. That distinction gives the show much of its value. The conversations also make room for the human stakes, including family experience with ALS and questions about genetic risk. Still, the center of gravity remains evidence. CReATe Podcast suits listeners who want research explained by people close to the work, with enough context to understand both promise and limits. It is sober, practical, and unusually comfortable saying that the answer is not known yet.

Made for: Suits a listener who wants patient-facing ALS research explanation without losing the clinical and trial-design details. It also fits families, advocates, and medically curious listeners comparing claims about alternative treatments against evidence.

What sets it apart: CReATe Podcast pairs consortium author interviews with ALS Untangled evidence reviews, so the same feed covers emerging research and practical questions about products advertised to people with ALS. Its strength is disciplined uncertainty: mechanisms, risks, and missing evidence stay visible.

In their own words

CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.

Why you'd press play

The Wahls diet gets an evidence check before you rearrange your grocery list.

Press play if you want

  • the ashwagandha evidence weighed without a miracle-cure flourish
  • the difference between moderate and extreme exercise treated as a research question, not a slogan
Read the full recommendation in PlayNext →
ALS therapy developmentALS Untangled treatment reviewsalternative and off-label treatmentsgenetic risk for ALS and FTDC9orf72 prevention trialsprodromal ALS and phenoconversionexercise, mTOR signaling, and ALSclinical trial endpoints and biomarkers

Talks about

Best episodes of CReATe Podcast

Short reviews from the PlayNext desk, based on the episodes we processed.

CReATe Author Series Ep. 18 - Dr. Michael Benatar on MMI as a prodromal stage of ALSApr 9, 2026

A measured guide to how MMI may sharpen early ALS research.

This CREATE Consortium episode gives mild motor impairment, or MMI, a clear role in ALS research by turning a clinical question into something listeners can follow. Dr.

CReATe Author Series Ep. 17 - (AI generated) Podcast on C9orf72 Disease Prevention TrialsJan 8, 2026

A focused look at how prevention trials define disease onset before they can claim to prevent it.

This PlayNext review of C9-ORF72 disease prevention trials turns on a difficult question in preventive neurology: how does a study know when inherited risk has become illness?

CReATe Author Series Ep. 16 - Dr. Johnathan Cooper-Knock on Exercise and ALSSep 24, 2025

A measured look at why extreme and moderate exercise may point in different directions for ALS risk.

Extreme exercise and ALS meet around a difficult biological question: why might very high activity be linked with higher risk while moderate exercise appears protective?

Podcasts like CReATe Podcast

Episodes

  1. 1

    CReATe Author Series Ep. 18 - Dr. Michael Benatar on MMI as a prodromal stage of ALS

    Hidden gem

    ["The CREATE Consortium Authors Podcast Series pairs Dr.

    Apr 9, 2026·31m·2 clips
  2. 2

    CReATe Author Series Ep. 17 - (AI generated) Podcast on C9orf72 Disease Prevention Trials

    Hidden gem

    CReATe Podcast Ep.

    Jan 8, 2026·26m·1 clip
  3. 3

    ALS Untangled Series Ep. 64 - Wahls Protocol

    Hidden gem

    Dr.

    Dec 10, 2025·17m·1 clip
  4. 4

    ALS Untangled Series Ep. 63 - Psilocybin

    Dr.

    Nov 17, 2025·10m
  5. 5

    ALS Untangled Series Ep. 62 - Ashwagandha

    Hidden gem

    Dr.

    Oct 20, 2025·17m·1 clip
  6. 6

    CReATe Author Series Ep. 16 - Dr. Johnathan Cooper-Knock on Exercise and ALS

    Hidden gem

    CReATe Podcast episode 16 follows Dr.

    Sep 24, 2025·19m·1 clip
  7. 7

    ALS Untangled Series Ep. 61 - Zinc

    CReATe Podcast’s ALS Untangled Series Ep.

    Sep 9, 2025·17m·1 clip
  8. 8

    CReATe Author Series Ep. 15 - Drs. Terry Heiman-Patterson and Michael Benatar on Clinical Guidance for ALS/FTD at-risk carriers

    Hidden gem

    Dr. Heiman-Patterson describes her new at-risk clinic: baseline neurofilament and EMG, no evidence for repeat intervals, and "seat of the pants" follow-up.

    Jun 2, 2025·33m·2 clips
  9. 9

    CReATe Author Series Ep. 14 - Drs. Ruben van Eijk and Michael Benatar on Phase 2 Trials and ALS

    Hidden gem

    Drs.

    May 1, 2025·37m·2 clips
  10. 10

    CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS

    Feb 18, 2025·27m
  11. 11

    CReATe Author Series Ep. 12 - Drs. Jesse Crayle and Evadnie Rampersaud on Genetics and ALS Reversal Phenotype

    Jan 2, 2025·26m
  12. 12

    ALS Untangled Series Ep. 60 - Nuedexta

    Dec 4, 2024·25m
  13. 13

    ALS Untangled Series Ep. 59 - Lions Mane

    Nov 4, 2024·17m
  14. 14

    ALS Untangled Series Ep. 58 - Insulin

    Oct 1, 2024·20m
  15. 15

    ALS Untangled Series Ep. 57 - Caffeine

    Sep 5, 2024·22m
  16. 16

    CReATe Author Series Ep. 11 - Dr. Benatar and the Miami Framework for ALS

    Aug 13, 2024·30m
  17. 17

    CReATe Author Series Ep. 10 - Drs. McHutchison and Benatar on Cognitive and Behavioral Changes in MND

    Feb 15, 2024·30m
  18. 18

    CReATe Author Series Ep. 9 - Drs. Heatwole and Benatar on Patient Reported Outcome Measures and ALS

    Jan 3, 2024·36m
  19. 19

    ALS Untangled Series Ep. 56 - Sodium Chlorite

    Dr.

    Nov 15, 2023·22m
  20. 20

    ALS Untangled Series Ep. 55 - Rituximab

    Oct 9, 2023·13m
  21. 21

    ALS Untangled Series Ep. 54 - Ozone Therapy

    Sep 5, 2023·19m
  22. 22

    ALS Untangled Series Ep. 53 - Astaxanthin

    Aug 8, 2023·21m
  23. 23

    CReATe Author Series Ep. 8 Part I - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS

    Jun 12, 2023·21m
  24. 24

    CReATe Author Series Ep. 8 Part II - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS

    Jun 12, 2023·25m
  25. 25

    ALS Untangled Series Ep. 52 - Antimycobacterial Antibiotics

    May 1, 2023·17m
  26. 26

    ALS Untangled Series Ep. 51 - Corticosteroids

    Apr 3, 2023·14m
  27. 27

    ALS Untangled Series Ep. 50 - Butyrate

    Mar 2, 2023·26m
  28. 28

    ALS Untangled Series Ep. 49 - Methylcobalamin

    Dr.

    Feb 8, 2023·27m
  29. 29

    CReATe Author Series: Ep. 7 - Drs. Jim Caress and Michael Benatar on Electronic Health Records and ALS research

    Jan 5, 2023·37m
  30. 30

    CReATe Author Series: Ep. 6 - Drs. Mary-Louise Rogers and Michael Benatar on Urine Biomarkers for ALS

    Sep 7, 2022·29m
  31. 31

    CReATe Author Series: Ep. 5 - Dr. Marc Weisskopf and Environmental Risk Factors in ALS

    Aug 17, 2022·33m
  32. 32

    CReATe Author Series: Ep. 4 - Drs. Melissa Nel and Jeannine Heckmann and African Genetic Diversity in ALS

    Jul 1, 2022·25m
  33. 33

    ALS Untangled Series Ep. 48 - Vitamin C

    Jun 1, 2022·12m
  34. 34

    ALS Untangled Series Ep. 47 - Melatonin

    May 3, 2022·18m
  35. 35

    ALS Untangled Series Ep. 46 - Light Therapy

    Apr 1, 2022·17m
  36. 36

    ALS Untangled Series: Ep. 45 - Ketogenic Diets

    Mar 3, 2022·17m
  37. 37

    CReATe Author Series: Ep. 3 - Dr. Michael Benatar and Neurofilament Biomarkers for ALS

    Dr.

    Dec 22, 2021·37m
  38. 38

    CReATe Author Series: Ep. 2 - Dr. Corey McMillan and Cognition in ALS

    Dr.

    Nov 5, 2021·30m
  39. 39

    CReATe Author Series: Ep. 1 - Dr. Benjamin Murdock and Immune Mechanisms in ALS

    Dr.

    Oct 4, 2021·24m
  40. 40

    ALS Untangled Series: Ep. 44 - Tamoxifen

    Jul 6, 2021·17m
  41. 41

    ALS Untangled Series: Ep. 43 - Spirulina (blue green algae)

    Jun 8, 2021·16m
  42. 42

    ALS Untangled Series: Ep. 42 - Lutimax

    May 21, 2021·14m
  43. 43

    ALS Untangled Series: Ep. 41 - Bee Venom

    Apr 29, 2021·13m
  44. 44

    ALS Untangled Series: Ep. 40 - Vinpocetine

    Jan 25, 2021·16m
  45. 45

    ALS Untangled Series: Ep. 39 - Apoaequorin (Prevagen)

    Jan 7, 2021·11m
  46. 46

    ALS Untangled Series: Ep. 38 - Azathioprine

    Dec 17, 2020·16m
  47. 47

    ALS Untangled Series: Ep. 37 - Accilion

    Nov 30, 2020·13m
  48. 48

    ALS Untangled Series: Ep. 36 - Vitamin E

    Oct 5, 2020·18m
  49. 49

    ALS Untangled Series: Ep. 35 - Leap2Bfit

    Sep 17, 2020·12m
  50. 50

    ALS Untangled Series: Ep. 34 - Ursodiol

    Aug 22, 2020·14m